Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.
Description
Develop, train, and implement your models in the cloud by utilizing cutting-edge IPU AI systems alongside your preferred frameworks, partnering with our cloud service providers. This approach enables you to reduce compute expenses while effortlessly scaling to extensive IPU resources whenever required. Begin your journey with IPUs now, taking advantage of on-demand pricing and complimentary tier options available through our cloud partners. We are confident that our Intelligence Processing Unit (IPU) technology will set a global benchmark for machine intelligence computation. The Graphcore IPU is poised to revolutionize various industries, offering significant potential for positive societal change, ranging from advancements in drug discovery and disaster recovery to efforts in decarbonization. As a completely novel processor, the IPU is specifically engineered for AI computing tasks. Its distinctive architecture empowers AI researchers to explore entirely new avenues of work that were previously unattainable with existing technologies, thereby facilitating groundbreaking progress in machine intelligence. In doing so, the IPU not only enhances research capabilities but also opens doors to innovations that could reshape our future.
API Access
Has API
API Access
Has API
Integrations
Cirrascale
Hugging Face
Keras
PaddlePaddle
PyTorch
TensorFlow
Integrations
Cirrascale
Hugging Face
Keras
PaddlePaddle
PyTorch
TensorFlow
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Atomwise
Founded
2012
Country
United States
Website
www.atomwise.com
Vendor Details
Company Name
Graphcore
Founded
2016
Country
United Kingdom
Website
www.graphcore.ai/
Product Features
Product Features
Artificial Intelligence
Chatbot
For Healthcare
For Sales
For eCommerce
Image Recognition
Machine Learning
Multi-Language
Natural Language Processing
Predictive Analytics
Process/Workflow Automation
Rules-Based Automation
Virtual Personal Assistant (VPA)